Home › Funds › Commodore Capital LP › LBRX

Commodore Capital LP position in LBRX

LB PHARMACEUTICALS INC · Health Care

Commodore Capital LP reported holding 1,500,000 shares of LBRX (LB PHARMACEUTICALS INC) in its Q2 2026 13F filing — a position valued at US$48.7M, representing 2.90% of its reported portfolio and ranking #15 among its reported holdings. Commodore Capital LP has disclosed LBRX holdings in 4 of the last 4 reported quarters, going back to Q3 2025.

Latest position (Q2 2026)1.50M sh
Reported value held$48.68M
Portfolio Weight2.90%
First reportedQ3 2025
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Commodore Capital LP's LBRX position evolved

Commodore Capital LP first disclosed a stake in LBRX in Q3 2025 at 1,500,000 shares (US$23.7M). The position peaked in Q2 2026 at 1,500,000 shares, worth US$48.7M. Across 4 filings, Commodore Capital LP held the position steady without any share-count change. The most recent filing (Q2 2026) shows 1,500,000 shares valued at US$48.7M.

Quarter by quarter

QuarterSharesValueChange
Q3 2025 1.50M $23.68M New
Q4 2025 1.50M $33.39M Hold
Q1 2026 1.50M $36.99M Hold
Q2 2026 1.50M $48.68M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About LBRX and 13F data

LBRX (LB PHARMACEUTICALS INC) is a Health Care company. 110 other funds we track also report a position in LBRX — the largest reported positions include Deep Track Capital, LP (US$108.8M), RA CAPITAL MANAGEMENT, L.P. (US$71.7M), Trails Edge Capital Partners, LP (US$49.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding LBRX

All LBRX fund holders →

FAQ

How long has Commodore Capital LP held LBRX?

Commodore Capital LP has disclosed LBRX holdings in 4 of the last 4 reported quarters, going back to Q3 2025.

What is Commodore Capital LP's current position in LBRX?

As of Q2 2026, Commodore Capital LP holds 1.50M shares of LBRX (LB PHARMACEUTICALS INC), valued at $48.68M, representing 2.90% of its reported portfolio and ranking #15.

Has Commodore Capital LP been buying or selling LBRX?

In the latest 13F filing (Q2 2026), Commodore Capital LP held unchanged its position in LBRX. The position peaked in Q2 2026 at 1.50M shares.

Which other funds hold LBRX?

Other major institutional holders of LBRX include Deep Track Capital, LP, RA CAPITAL MANAGEMENT, L.P., Trails Edge Capital Partners, LP, among 110 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.